The global immuno-oncology assay market is estimated to be worth USD 5.6 billion in 2024 and is projected to be valued at USD 18.1 billion in 2034. Between 2024 and 2034, the industry is expected to register a CAGR of 12.4%. The increasing adoption of immunotherapy in cancer treatment is driving the demand for immuno-oncology …
Continue reading “Global Immuno-Oncology Assay Market is expected to reach USD 18.1 billion by 2034”